Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway

Osteosarcoma (OS) is the most common malignant bone tumor occurring mostly in children and adolescents between 10 and 20 years of age with poor response to current therapeutics. Alisertib (ALS, MLN8237) is a selective Aurora kinase A inhibitor that displays anticancer effects on several types of can...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Drug Des Devel Ther
Hoofdauteurs: Niu, Ning-Kui, Wang, Zi-Li, Pan, Shu-Ting, Ding, Hui-Qiang, Au, Giang HT, He, Zhi-Xu, Zhou, Zhi-Wei, Xiao, Guozhi, Yang, Yin-Xue, Zhang, Xueji, Yang, Tianxin, Chen, Xiao-Wu, Qiu, Jia-Xuan, Zhou, Shu-Feng
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove Medical Press 2015
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4362906/
https://ncbi.nlm.nih.gov/pubmed/25792811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S74197
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items